Fresenius Medical Care AG & Co. KGaA provides dialysis care and related services primarily in Germany and North America, along with international markets. The company generates revenue through its outpatient dialysis clinics, which account for approximately 60-70% of total revenue, and the sale of dialysis products, contributing around 30-40%. Key products include dialysis machines, dialyzers, and renal pharmaceuticals. Factors supporting the company's endurance include a growing global prevalence of chronic kidney disease and a strong network of clinics. However, regulatory changes and competition from other healthcare providers may pose challenges.
—
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related services primarily in Germany and North America, along with international markets. The company generates revenue through its outpatient dialysis clinics, which account for approximately 60-70% of total revenue, and the sale of dialysis products, contributing around 30-40%. Key products include dialysis machines, dialyzers, and renal pharmaceuticals. Factors supporting the company's endurance include a growing global prevalence of chronic kidney disease and a strong network of clinics. However, regulatory changes and competition from other healthcare providers may pose challenges.
—
Daily adjusted close
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related services primarily in Germany and North America, along with international markets. The company generates revenue through its outpatient dialysis clinics, which account for approximately 60-70% of total revenue, and the sale of dialysis products, contributing around 30-40%. Key products include dialysis machines, dialyzers, and renal pharmaceuticals. Factors supporting the company's endurance include a growing global prevalence of chronic kidney disease and a strong network of clinics. However, regulatory changes and competition from other healthcare providers may pose challenges.